Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

TB/FLU-06E Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis.

Autor: Shurygina AS; Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, 197022 Saint-Petersburg, Russia., Zabolotnykh NV; Saint-Petersburg State Research Institute of Phthisiopulmonology, The Ministry of Health of the Russian Federation, 194064 Saint-Petersburg, Russia., Vinogradova TI; Saint-Petersburg State Research Institute of Phthisiopulmonology, The Ministry of Health of the Russian Federation, 194064 Saint-Petersburg, Russia., Vitovskaya ML; Saint-Petersburg State Research Institute of Phthisiopulmonology, The Ministry of Health of the Russian Federation, 194064 Saint-Petersburg, Russia., Dogonadze MZ; Saint-Petersburg State Research Institute of Phthisiopulmonology, The Ministry of Health of the Russian Federation, 194064 Saint-Petersburg, Russia., Vasilyev KA; Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, 197022 Saint-Petersburg, Russia., Buzitskaya ZV; Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, 197022 Saint-Petersburg, Russia., Yablonskiy PK; Saint-Petersburg State Research Institute of Phthisiopulmonology, The Ministry of Health of the Russian Federation, 194064 Saint-Petersburg, Russia., Lioznov DA; Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, 197022 Saint-Petersburg, Russia., Stukova MA; Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, 197022 Saint-Petersburg, Russia.

Publikováno v: Pharmaceutics [Pharmaceutics] 2024 Jun 25; Vol. 16 (7). Date of Electronic Publication: 2024 Jun 25.

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2.

Autor: Vasin AV; Smorodintsev Research Institute of Influenza, Saint Petersburg, Russia; Institute of Biomedical Systems and Biotechnologies, Peter the Great St Petersburg Polytechnic University, Saint Petersburg, 195251, Russia. Electronic address: vasin_av@spbstu.ru., Stukova MA; Smorodintsev Research Institute of Influenza, Saint Petersburg, Russia.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Aug; Vol. 23 (8), pp. 880-881. Date of Electronic Publication: 2023 Apr 21.

SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19.

Autor: Stanevich OV; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia., Alekseeva EI; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia. evg.alekseeva93@gmail.com., Sergeeva M; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia., Fadeev AV; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia., Komissarova KS; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia., Ivanova AA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia., Simakova TS; Parseq Lab Co. Ltd, Saint Petersburg, Russia., Vasilyev KA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia., Shurygina AP; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia., Stukova MA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia., Safina KR; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia., Nabieva ER; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia., Garushyants SK; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA., Klink GV; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia., Bakin EA; First Pavlov State Medical University, Saint-Petersburg, Russia.; Bioinformatics Institute, Saint Petersburg, Russia., Zabutova JV; City Hospital 31, Saint-Petersburg, Russia., Kholodnaia AN; First Pavlov State Medical University, Saint-Petersburg, Russia.; City Hospital 31, Saint-Petersburg, Russia., Lukina OV; First Pavlov State Medical University, Saint-Petersburg, Russia., Skorokhod IA; City Hospital 31, Saint-Petersburg, Russia., Ryabchikova VV; City Hospital 31, Saint-Petersburg, Russia., Medvedeva NV; City Hospital 31, Saint-Petersburg, Russia., Lioznov DA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.; First Pavlov State Medical University, Saint-Petersburg, Russia., Danilenko DM; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia., Chudakov DM; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Komissarov AB; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia., Bazykin GA; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia. g.bazykin@skoltech.ru.; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia. g.bazykin@skoltech.ru.

Publikováno v: Nature communications [Nat Commun] 2023 Jan 10; Vol. 14 (1), pp. 149. Date of Electronic Publication: 2023 Jan 10.

SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.

Autor: Vakhrusheva AV; Betuvax LLC, 121096 Moscow, Russia.; Department of Bioengineering, Biological Faculty, Lomonosov Moscow State University, 119991 Moscow, Russia., Kudriavtsev AV; Betuvax LLC, 121096 Moscow, Russia.; Department of Bioengineering, Biological Faculty, Lomonosov Moscow State University, 119991 Moscow, Russia., Kryuchkov NA; Clinical Excellence Group LLC, 127051 Moscow, Russia., Deev RV; Department of Pathological Anatomy, I.I. Mechnikov North-Western State Medical University, 195067 Saint Petersburg, Russia., Frolova ME; PJSC Human Stem Cells Institute, 129110 Moscow, Russia., Blagodatskikh KA; Center of Genetics and Reproductive Medicine 'Genetico', 119333 Moscow, Russia., Djonovic M; Betuvax LLC, 121096 Moscow, Russia., Nedorubov AA; Center for Preclinical Studies, Sechenov First Moscow State Medical University, 119435 Moscow, Russia., Odintsova E; Center for Preclinical Studies, Sechenov First Moscow State Medical University, 119435 Moscow, Russia., Ivanov AV; Biotechnology Developments LLC, 119285 Moscow, Russia., Romanovskaya-Romanko EA; Department of Vaccinology, Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia., Stukova MA; Department of Vaccinology, Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia., Isaev AA; PJSC Human Stem Cells Institute, 129110 Moscow, Russia.; Center of Genetics and Reproductive Medicine 'Genetico', 119333 Moscow, Russia., Krasilnikov IV; Biotechnology Developments LLC, 119285 Moscow, Russia.; Department of Vaccinology, Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia.

Publikováno v: Vaccines [Vaccines (Basel)] 2022 Aug 10; Vol. 10 (8). Date of Electronic Publication: 2022 Aug 10.